Literature DB >> 16176390

Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia.

F Zhang1, D St Clair, X Liu, X Sun, P C Sham, C Crombie, X Ma, Q Wang, H Meng, W Deng, P Yates, X Hu, N Walker, R M Murray, D A Collier, T Li.   

Abstract

We investigated the RGS4 as a susceptibility gene for schizophrenia in Chinese Han (184 trios and 138 sibling pairs, a total of 322 families) and Scottish (580 cases and 620 controls) populations using both a family trio and case-control design. Both the samples had statistical power greater than 70% to detect a heterozygote genotype relative risk of >1.2 for frequent RGS4-risk alleles. We genotyped four single nucleotide polymorphisms (SNPs) which have previously been associated with schizophrenia as either individually or part of haplotypes. Allele frequencies and linkage disequilibrium between the SNPs was similar in the two populations. In the Chinese sample, no individual SNPs or any of their haplotypes were associated with schizophrenia. In the Scottish population, one SNP (SNP7) was significantly over-represented in the cases compared with the controls (0.44 vs. 0.38; A allele; chi(2) 7.08, P = 0.011 after correction for correlation between markers by permutation testing). One two-marker haplotype, composed of alleles T and A of SNP4 and SNP7, respectively, showed individual significance after correction by permutation testing (chi(2) 6.8; P = 0.04). None of the full four-marker haplotypes showed association, including the G-G-G-G haplotype previously associated with schizophrenia in more than one sample and the A-T-A-A haplotype. Thus, our data do not directly replicate previous associations of RGS4, but association with SNP 7 in the Scottish population provides some support for a role in schizophrenia susceptibility. We cannot conclusively exclude RGS4, as associated haplotypes are likely to be surrogates for unknown causative alleles, whose relationship with overlying haplotypes may differ between the population groups. Differences in the association seen across the two populations could result from methodological factors such as diagnostic differences but most likely result from ethnic differences in haplotype structures within RGS4.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176390     DOI: 10.1111/j.1601-183X.2005.00167.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  13 in total

Review 1.  Genomic structural variation and schizophrenia.

Authors:  Jennifer Gladys Mulle
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

2.  Association of polymorphisms in RGS4 and expression of RGS transcripts in the brains of human alcoholics.

Authors:  Ada M-C Ho; Rachel K MacKay; Peter R Dodd; Joanne M Lewohl
Journal:  Brain Res       Date:  2010-04-27       Impact factor: 3.252

3.  Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia.

Authors:  Kristin K Nicodemus; Bhaskar S Kolachana; Radhakrishna Vakkalanka; Richard E Straub; Ina Giegling; Michael F Egan; Dan Rujescu; Daniel R Weinberger
Journal:  Hum Genet       Date:  2006-09-28       Impact factor: 4.132

4.  Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia.

Authors:  Kodavali V Chowdari; Mikhil Bamne; Joel Wood; Michael E Talkowski; Karoly Mirnics; Pat Levitt; David A Lewis; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-05-21       Impact factor: 9.306

Review 5.  Can RGS4 polymorphisms be viewed as credible risk factors for schizophrenia? A critical review of the evidence.

Authors:  Michael E Talkowski; Kv Chowdari; David A Lewis; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2006-02-09       Impact factor: 9.306

6.  Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.

Authors:  Daniel B Campbell; Philip J Ebert; Tara Skelly; T Scott Stroup; Jeffrey Lieberman; Pat Levitt; Patrick F Sullivan
Journal:  Biol Psychiatry       Date:  2007-06-22       Impact factor: 13.382

7.  Association of RGS2 and RGS5 variants with schizophrenia symptom severity.

Authors:  Daniel B Campbell; Leslie A Lange; Tara Skelly; Jeffrey Lieberman; Pat Levitt; Patrick F Sullivan
Journal:  Schizophr Res       Date:  2008-02-11       Impact factor: 4.939

Review 8.  Dopaminergic intracellular signal integrating proteins: relevance to schizophrenia.

Authors:  Bruno R Souza; Renan P Souza; Daniela V F Rosa; Melissa M Guimarães; Humberto Correa; Marco A Romano-Silva
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

9.  Deletion of PLCB1 gene in schizophrenia-affected patients.

Authors:  Vincenza Rita Lo Vasco; Giuseppina Cardinale; Patrizia Polonia
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

10.  Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population level.

Authors:  Nicholas C Stefanis; Thomas A Trikalinos; Dimitrios Avramopoulos; Nikos Smyrnis; Ioannis Evdokimidis; Evangelia E Ntzani; Alex Hatzimanolis; John Pa Ioannidis; Costas N Stefanis
Journal:  Behav Brain Funct       Date:  2008-10-03       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.